# Clarity Pharmaceuticals

Type: Company (CU6)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/clarity-pharmaceuticals
Canonical HTML page: https://getbiobrief.com/entity/clarity-pharmaceuticals

## Recent coverage (2 stories)

### Clarity Secures Large-Scale Cu-64 Supply Agreement with Theragenics
2026-03-25 18:09:08 · Sentiment: Positive · Impact: 6/10 · Sources: 2

Clarity Pharmaceuticals has signed a major manufacturing supply agreement with Theragenics to secure large-scale production of copper-64. This partnership bolsters the supply chain for Clarity’s Targeted Copper Theranostics platform as it moves toward late-stage clinical trials.
Full story: https://getbiobrief.com/story/clarity-theragenics-copper-64-supply-agreement

### Biotech’s Two-Speed Market: Innovation Defies Regulatory Headwinds
2026-02-25 00:12:53 · Sentiment: Neutral · Impact: 6/10 · Sources: 5

The global biotech sector has diverged into a 'two-speed' market, where innovative drug discovery and device firms are outperforming established healthcare heavyweights. Despite regulatory uncertainty under the Trump administration and a 25% decline in the ASX 200 healthcare sector, the Nasdaq Biotech Index has surged 30%, supported by record-breaking capital raises.
Full story: https://getbiobrief.com/story/biotech-two-speed-market-analysis-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.